Inhibiting KDM6A Phosphorylation Suppresses Glycolysis in Oral Squamous Cell Carcinoma
Oral Diseases · 2025
DOI: 10.1111/odi.70142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Xin Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shan…. Hauptthemen laut MEDLINE: Glycolysis, Carcinoma, Squamous Cell, Mouth Neoplasms, Histone Demethylases. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China (82272815 and 82073384), The Double Hundred Plan of Shanghai Jiao Tong University School of Medicine (20191812).
Abstract (Originalsprache)
Objectives
Although KDM6A plays a pivotal role in various diseases, particularly cancer, the mechanisms underlying its influence on metabolism remain largely elusive. In this study, we aim to reveal a specific post‐translational modification of KDM6A to modulate glycolysis in oral squamous cell carcinoma (OSCC). Subjects and Methods Co‐IP and immunoblotting assays were performed to identify KDM6A‐pSer829 as a substrate of E3 ubiquitin ligase F‐Box and WD Repeat Domain Containing 7 (FBXW7). Phospho‐dead Kdm6a S829A conditional knock‐in mice were generated. The tongue tissues from these mice were collected for single‐cell RNA sequencing (scRNA‐Seq). Using 4‐nitroquinoline‐1‐oxide (4NQO) induced OSCC models in mice, the effect of KDM6A‐pS829 on cell proliferation was examined by immunofluorescent imaging.
Results
Co‐IP and immunoblotting established that KDM6A‐pSer829 was a critical FBXW7 recognition site, leading to its ubiquitination and degradation. scRNA‐Seq analysis of tongue tissues demonstrated significantly downregulated glycolysis in Kdm6a‐S829A mouse oral squamous cells compared to wild‐type controls. Furthermore, the Kdm6a‐S829A mutation suppressed cell proliferation in 4NQO‐induced in vivo OSCC models.
Conclusions
Our findings demonstrate that KDM6A‐pSer829, targeted by FBXW7 for ubiquitination and degradation, promotes glycolysis and cell proliferation in OSCC. This establishes KDM6A‐pSer829 as a critical regulator of OSCC metabolism and tumorigenesis, highlighting its potential as a novel therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- National Clinical Research Center for Oral Disease, Shanghai, China.
- Shanghai Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai, China.
ORCID-Profile: Xu Wang
Förderung
- National Natural Science Foundation of China (82272815 and 82073384)
- The Double Hundred Plan of Shanghai Jiao Tong University School of Medicine (20191812)
Zitieren
APA
Chen, X., Hu, X., Chen, J., Ji, Y., Pan, X., & Wang, X. (2025). Inhibiting KDM6A Phosphorylation Suppresses Glycolysis in Oral Squamous Cell Carcinoma. Oral Diseases. https://doi.org/10.1111/odi.70142
Vancouver
Chen X, Hu X, Chen J, Ji Y, Pan X, Wang X. Inhibiting KDM6A Phosphorylation Suppresses Glycolysis in Oral Squamous Cell Carcinoma. Oral Diseases. 2025. doi:10.1111/odi.70142
BibTeX
@article{Chen2025,
author = {Chen, Xin and Hu, Xin and Chen, Jun and Ji, Yikang and Pan, Xinhua and Wang, Xu},
title = {Inhibiting KDM6A Phosphorylation Suppresses Glycolysis in Oral Squamous Cell Carcinoma},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.70142}
}
EUVIMED